secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acumen Pharmaceuticals, Inc. (ABOS)
CIK:        0001576885
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001576885-24-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acumen posts updated corporate presentation with additional ACU193 biomarker data at J.P. Morgan Healthcare Conference
--------------------------------------------------------------------------------

- Company posted updated corporate presentation on its website with additional biomarker data for ACU193.
- Presentation used at J.P. Morgan Healthcare Conference on January 8, 2024.
- No specific financial results or guidance changes disclosed.
- ACU193 is an investigational drug for Alzheimer's disease.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576885/000157688524000015/0001576885-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576885/000157688524000015/abos-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001576885-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer